Investor

Active Biotech is developing pharmaceutical products within medical areas where the immune defense is of significant importance like inflammatory disease and various forms of cancer.

Active Biotech’s share is listed on the NASDAQ OMX Nordic Exchange (Stockholm) since 1986 and the company has approximately 15,000 shareholders.

Short Name
ACTI

Financial Reports

Latest Presentation

Active Biotech presentation at Aktiespararnas “Aktiedag Lund” (in Swedish)

Helén Tuvesson

IR Contact

Phone: +46 46 19 21 56

E-mail: helen.tuvesson@activebiotech.com

Hans Kolam

IR Contact

Phone: +46 46 19 20 44

E-mail: hans.kolam@activebiotech.com